Aurora, Colorado
CNS medication trials in Aurora, CO
22 CNS medication studies are recruiting participants at sites in Aurora as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Aurora at a glance
- 22 studies are recruiting at a site in Aurora.
- By phase: Phase 1/2 (1), Phase 2 (4), Phase 2/3 (1), Phase 3 (11), Phase 4 (4), No phase (1). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (15), university, hospital or other (6), government (1).
- By research area: Migraine (6), Parkinson's Disease (6), Depression (4), Epilepsy (3), Multiple Sclerosis (3).
- Most recent update to one of these records: November 17, 2026.
Depression studies recruiting in Aurora
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Study site
- University of Colorado
- Registry record
- NCT07002034 · updated
Brexanolone Lifting Outcomes Of Moms
- Phase 3
- Ages 15 to 45
- Female participants
- Sponsor
- Lipocine Inc.
- Study site
- Lipocine Investigational Site
- Registry record
- NCT07822321 · updated
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06963021 · updated
Cannabis for Palliative Care in Cancer
- Phase 2
- Ages 25 and older
- All sexes
- Sponsor
- University of Colorado, Boulder
- Study site
- Anschutz Health Sciences Building
- Registry record
- NCT06266611 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Aurora, CO on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Aurora
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Colorado Anschutz Medical Campus ( Site 0151)
- Registry record
- NCT06623422 · updated
An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
- Phase 2
- Ages 50 to 80
- All sexes
- Sponsor
- Yale University
- Study site
- University of Colorado Anschutz
- Registry record
- NCT06996652 · updated
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Phase 2
- Ages 40 to 80
- All sexes
- Sponsor
- Neuron23 Inc.
- Study site
- University of Colorado - Anschutz Medical Campus
- Registry record
- NCT06680830 · updated
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Phase 2/3
- Ages 40 to 80
- All sexes
- Sponsor
- Biohaven Therapeutics Ltd.
- Registry record
- NCT06976268 · updated
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- University of Colorado Anschutz Medical Campus ( Site 0061)
- Registry record
- NCT06312176 · updated
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- Phase 4
- Ages 40 and older
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- Rocky Mountain Regional VA Medical Center, Aurora, CO
- Registry record
- NCT04373317 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Aurora, CO on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Aurora
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- UC Health Neuroscience Ctr
- Registry record
- NCT07225504 · updated
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Sanofi
- Study site
- Rocky Mountain Regional VA Medical Center- Site Number : 8400121
- Registry record
- NCT07325292 · updated
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod
- Phase 4
- Ages 18 and older
- All sexes
- Sponsor
- University of Colorado, Denver
- Study site
- University of Colorado Anschutz Medical Campus
- Registry record
- NCT06529406 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Aurora, CO on ClinicalTrials.gov.
Epilepsy studies recruiting in Aurora
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
- Phase 1/2
- From 6 months, up to 17 years
- All sexes
- Sponsor
- Encoded Therapeutics
- Study site
- Colorado Children's Hospital
- Registry record
- NCT05419492 · updated
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
- Phase 3
- From 1 day, up to 18 years
- All sexes
- Sponsor
- Praxis Precision Medicines
- Study site
- Praxis Research Site
- Registry record
- NCT07019922 · updated
Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age
- Phase 4
- From 12 months, up to 24 months
- All sexes
- Sponsor
- University of Colorado, Denver
- Study site
- Children's Hospital Colorado
- Registry record
- NCT06598449 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Aurora, CO on ClinicalTrials.gov.
Migraine studies recruiting in Aurora
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Study site
- University of Colorado Anschutz Medical Campus
- Registry record
- NCT06972056 · updated
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Paradigm Clinical Research Centers, LLC; Aurora
- Registry record
- NCT07816367 · updated
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study sites
- Children's Hospital Colorado · Children's Hospital Colorado- lnvestigational Drug Services
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study sites
- Children's Hospital Colorado · Children's Hospital Colorado- Investigational Drug Services
- Registry record
- NCT04743141 · updated
Responding With Evidence and Access for Childhood Headaches
- No phase
- Ages 10 to 17
- All sexes
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Study site
- University of Colorado/Children's Hospital Colorado
- Registry record
- NCT05889624 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study sites
- Children's Hospital Colorado - Aurora /ID# 231879 · Paradigm Clinical Research - Aurora, CO /ID# 280612
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Aurora, CO on ClinicalTrials.gov.
Ask about studies near Aurora
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections